A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation
- PMID: 38709933
- PMCID: PMC11098111
- DOI: 10.1073/pnas.2306776121
A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation
Abstract
A high-fat diet (HFD) is a high-risk factor for the malignant progression of cancers through the disruption of the intestinal microbiota. However, the role of the HFD-related gut microbiota in cancer development remains unclear. This study found that obesity and obesity-related gut microbiota were associated with poor prognosis and advanced clinicopathological status in female patients with breast cancer. To investigate the impact of HFD-associated gut microbiota on cancer progression, we established various models, including HFD feeding, fecal microbiota transplantation, antibiotic feeding, and bacterial gavage, in tumor-bearing mice. HFD-related microbiota promotes cancer progression by generating polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Mechanistically, the HFD microbiota released abundant leucine, which activated the mTORC1 signaling pathway in myeloid progenitors for PMN-MDSC differentiation. Clinically, the elevated leucine level in the peripheral blood induced by the HFD microbiota was correlated with abundant tumoral PMN-MDSC infiltration and poor clinical outcomes in female patients with breast cancer. These findings revealed that the "gut-bone marrow-tumor" axis is involved in HFD-mediated cancer progression and opens a broad avenue for anticancer therapeutic strategies by targeting the aberrant metabolism of the gut microbiota.
Keywords: breast cancer; gut microbiota; high-fat diet; myeloid-derived suppressor cells.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Similar articles
-
Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes.Anticancer Res. 2024 Jun;44(6):2271-2285. doi: 10.21873/anticanres.17035. Anticancer Res. 2024. PMID: 38821615 Review.
-
High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism.Int J Biol Sci. 2023 Sep 25;19(15):5004-5019. doi: 10.7150/ijbs.86717. eCollection 2023. Int J Biol Sci. 2023. PMID: 37781523 Free PMC article.
-
Beneficial Effects of Dietary Polyphenols on High-Fat Diet-Induced Obesity Linking with Modulation of Gut Microbiota.J Agric Food Chem. 2020 Jan 8;68(1):33-47. doi: 10.1021/acs.jafc.9b06817. Epub 2019 Dec 27. J Agric Food Chem. 2020. PMID: 31829012 Review.
-
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.Int J Mol Sci. 2019 Apr 18;20(8):1916. doi: 10.3390/ijms20081916. Int J Mol Sci. 2019. PMID: 31003475 Free PMC article.
-
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.J Leukoc Biol. 2018 Mar;103(3):395-407. doi: 10.1002/JLB.4HI0517-210R. Epub 2018 Jan 3. J Leukoc Biol. 2018. PMID: 29345342 Free PMC article.
Cited by
-
Fat, Desulfovibrio and cancer.Nat Rev Microbiol. 2024 Jul;22(7):388. doi: 10.1038/s41579-024-01061-x. Nat Rev Microbiol. 2024. PMID: 38769461 No abstract available.
-
Gut microbes linked to fatty diet drive tumour growth.Nature. 2024 May 16. doi: 10.1038/d41586-024-01443-4. Online ahead of print. Nature. 2024. PMID: 38755304 No abstract available.
References
-
- Flegal K. M., Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303, 235–241 (2010). - PubMed
-
- Calle E. E., Kaaks R., Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579–591 (2004). - PubMed
-
- van Kruijsdijk R. C., van der Wall E., Visseren F. L., Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev. 18, 2569–2578 (2009). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2019BT02Y198/Program for Guangdong Introducing Innovative and Enterpreneurial Teams
- 82330056/Natural Science Foundation of China
- 81730077/National Natural Science Foundation of China
- 92159303/National Natural Science Foundation of China
- 81930081/National Natural Science Foundation of China
- 82025026/National Natural Science Foundation of China
- 2022A1515110069/GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()
- 2023B1212060013/Guangdong Science and Technology Department
- 20212200003/Bureau of Science and Technology of Guangzhou
- E2018096/Guang Dong Cheung Kong philanthropy Foundation
LinkOut - more resources
Full Text Sources
Medical